Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cogstate Ltd (AU:CGS)
ASX:CGS
Cogstate Ltd (CGS) Share Price & Analysis
3 Followers
CGS Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$1.13 - AU$1.87
Previous CloseAU$1.24
Volume4.78K
Average Volume (3M)100.56K
Market Cap
AU$211.70M
Enterprise ValueAU$167.65M
Total Cash (Recent Filing)$30.60M
Total Debt (Recent Filing)$1.41M
Price to Earnings (P/E)25.8
Beta0.69
Next Earnings
Aug 22, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding171,419,328
10 Day Avg. Volume286,795
30 Day Avg. Volume100,559
Standard Deviation0.20
R-Squared0.00367
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)7.04
Price to Sales (P/S)2.82
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.28
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$1.80Price Target Upside44.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Cogstate Ltd News
PremiumCompany Announcements
Cogstate Ltd Announces Share Buy-Back Update
PremiumCompany Announcements
Cogstate Ltd Continues Share Buy-Back Initiative
PremiumCompany Announcements
Cogstate Ltd Continues Share Buy-Back Initiative
PremiumCompany Announcements
Cogstate Ltd Continues Share Buy-Back Program
PremiumCompany Announcements
Cogstate Continues Aggressive Share Buy-Back
PremiumCompany Announcements
Cogstate Ltd Continues Share Buy-Back Effort
PremiumCompany Announcements
Cogstate Ltd Options Cease Amid Unmet Conditions
PremiumCompany Announcements
Cogstate Ltd Seeks Quotation for New SecuritiesOptions Prices
Currently, No data available
---
Ownership Overview
35.23%
Insiders
1.94% Mutual Funds
0.03% Other Institutional Investors
62.81% Public Companies and
Individual Investors
CGS FAQ
What was Cogstate Ltd’s price range in the past 12 months?
Cogstate Ltd lowest share price was AU$1.13 and its highest was AU$1.87 in the past 12 months.
What is Cogstate Ltd’s market cap?
Currently, no data Available
When is Cogstate Ltd’s upcoming earnings report date?
Cogstate Ltd’s upcoming earnings report date is Aug 22, 2024 which is in 100 days.
How were Cogstate Ltd’s earnings last quarter?
Cogstate Ltd released its earnings results on Feb 21, 2024. The company reported AU$0.018 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.018.
Is Cogstate Ltd overvalued?
According to Wall Street analysts Cogstate Ltd’s price is currently Undervalued.
Does Cogstate Ltd pay dividends?
Cogstate Ltd does not currently pay dividends.
What is Cogstate Ltd’s EPS estimate?
Cogstate Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cogstate Ltd have?
Cogstate Ltd has 171,419,330 shares outstanding.
What happened to Cogstate Ltd’s price movement after its last earnings report?
Cogstate Ltd reported an EPS of AU$0.018 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -6.349%.
Which hedge fund is a major shareholder of Cogstate Ltd?
Currently, no hedge funds are holding shares in AU:CGS
---
Cogstate Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$1.80 (44.78% Upside)
AU$1.80 (44.78% Upside)
Blogger Sentiment
Bullish
AU:CGS Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.19%
12-Months-Change
Fundamentals
Return on Equity
15.37%
Trailing 12-Months
Asset Growth
-5.17%
Trailing 12-Months
Company Description
Cogstate Ltd
Cogstate Ltd is a cognitive science company. The principal activity of the company is a sale of technology and services for the measurement of cognition, where services include scientific consultancy, project management, data management, statistical analysis and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In clinical trials segment, technology and services are sold to pharmaceutical, biotechnology, nutraceutical, and functional food companies.
---
CGS Company Deck
---
CGS Earnings Call
Q2 2024
0:00 / 0:00
---
CGS Stock 12 Month Forecast
Average Price Target
AU$1.80
▲(44.78% Upside)
Technical Analysis
Cellectar Biosciences
―
Cel-Sci
―
Cyclacel Pharmaceuticals
―
Merck & Company
―
Cogstate Ltd
―
Best Analysts Covering CGS
1 Year
1 Year Success Rate
1/9 ratings generated profit
1 Year Average Return
-17.69%
reiterated a buy rating 3 months ago
Copying Elyse Shapiro's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -17.69% per trade.
---